Objective Elevated serum bilirubin concentrations protect from atherosclerotic diseases, however it is not clear whether or not higher serum bilirubin concentrations have the same effect in coronary artery disease (CAD). The brachial-ankle pulse wave velocity (baPWV) is a reproducible method to assess arterial stiffness. This study was aimed to investigate the relationship between serum total bilirubin (TB) and baPWV in patients with established CAD. Methods We enrolled 638 patients (390 men, 248 women) with established CAD. TB was divided into tertiles. Simple and multiple linear regression analyses were used to assess the correlation between baPWV and TB. Results The mean baPWV tended to decrease in men according to TB tertiles: Tertile 1=2,126.0, Tertile 2= 1,832.5, and Tertile 3=1,692.5 cm/s. Likewise, the mean baPWV tended to decrease in women according to TB tertiles: Tertile 1=1,920.8, Tertile 2=1,829.0, and Tertile 3=1,701.3 cm/s. Univariate analysis showed that age, BMI, TB, ALT, GGT, Cho, SBP, DBP, UA, and TC were significantly associated with baPWV in men. In women, age, BMI, current smoker, Cho, SBP, DBP, UA, TC, TG, HDL-C, and LDL-C were significantly associated with baPWV. BMI, LnSBP, UA, TB, LnCho, and LnTC were correlated with baPWV in men in the multivariate model. However, only LnSBP, UA, and LnHDL-C were correlated with baPWV in women. TB was found to be a significant determinant for decreased baPWV only in men (β=-0.136; p<0.001). Conclusion Our findings show that the level of total serum bilirubin is negatively correlated with arterial stiffness in men with established CAD.
Introduction
Large artery stiffness and arterial wave reflections are important determinants of left ventricular function, coronary blood flow, and mechanical integrity of the arteries. Elevated arterial stiffness, an index of subclinical atherosclerosis, is linked with myocardial infarction, heart failure, stroke, dementia, renal disease, and elevated total mortality (1) . Increased arterial stiffness, determined invasively, has been antioxidant molecule. It is a potent scavenger of reactive oxygen species under physiological conditions (8) . As an antioxidant, it has been shown to suppress the oxidation of lipids and lipoproteins, especially low-density lipoprotein (LDL) cholesterol (9) , and to be directly related to the total serum antioxidant capacity in humans (10) . High-normal serum levels of bilirubin are inversely related to the atherogenic risk, possibly by inhibitory effects against LDL oxidation and the scavenging of oxygen radicals (11, 12) . Low serum bilirubin concentrations were found to be related to an increased risk of CAD, whereas high-normal concentrations were found to be associated with a decreased risk of CAD. Serum bilirubin concentrations were inversely related to the severity of CAD and this inverse association occurs in both men and women (13, 14) . In addition, there is some evidence that bilirubin has anti-inflammatory properties (15) that inhibit tumor necrosis factor-α (TNF-α)-induced upregulation of E-selectin, vascular cell adhesion molecule 1 (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) in vitro (16) .
Recent studies have underlined the role of inflammation in the stiffening of large arteries. The inflammation process, either acute during vaccination against Salmonella typhi (17) , or chronic during rheumatoid arthritis (18, 19) or systemic lupus erythematosus (17) , has been reported to stiffen the large arteries. The association between arterial stiffening and inflammation in essential hypertension was demonstrated through the relationships between arterial stiffness and either TNF-α, interleukin-6 (IL-6), or high sensitive C-reactive protein (hs-CRP) (20, 21) . However, information is lacking on the influence of serum bilirubin levels in physiologic ranges on pulsatile arterial function in CAD. The association between bilirubin and the rate of mortality or incidence of stroke was different between genders (22) . In addition, other groups have suggested that hyperbilirubinemia is linked to pulmonary arterial hypertension and chronic heart failure (23, 24) . Therefore, the purpose of this study was to investigate whether or not the serum bilirubin level is independently associated with baPWV in established CAD.
Materials and Methods

Study patients
During the period from October 2010 to February 2012, 638 patients from the Department of Cardiovascular Diseases, the Third Affiliated Hospital of Sun Yat-Sen University were analyzed. The inclusion criteria were an established angiographic CAD diagnosis, characterized by the accomplishment of coronary angiography or elective myocardial revascularization procedures, as determined by an assisting physician. A lesion was defined as significant if it caused a 50% reduction of the luminal diameter by visual estimation in vessels ! 1.5 mm. All procedures were approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-Sen University.
Clinical examination
Clinical data including medical history, smoking status and medications used were recorded for each participant. All of the patients had a clinical examination which included anthropometric and blood pressure measurements. Blood pressure was measured by doctors in the right arm, which was placed at the heart level, with a standard mercury sphygmomanometer after the subject had been sitting quietly for more than 5 minutes; three blood pressure measurements, taken 60 seconds apart, were recorded. The average of the three systolic blood pressure (SBP) and diastolic blood pressure (DBP) values was used in our analyses. The weight and height of the participants were determined with a calibrated scale after the patient removed their shoes and any heavy clothing. Body mass index (BMI) was calculated as the ratio of weight divided by height squared (kg/m 2 ).
Laboratory data
Blood specimens were collected from all patients after overnight fasting for at least 12 hours. The values included total serum bilirubin concentrations, aspartate aminotransferase (AST), alanine aminotransferase (ALT), gammaglutamyl transpeptidase (GGT), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and fasting plasma glucose (FPG). The assays were performed at the Laboratory of Analytical Biochemistry at The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, using a biochemical analyzer (Hitachi 7180, Japan) employing standard methods.
Measurement of baPWV
baPWV was assessed by using a fully automatic device (Omron Healthcare, Kyoto, Japan). The patients rested in the supine position for 5 minutes. The baPWV was automatically calculated according to the formula (L/PTT). L is difference between the length from heart to ankle and the length from heart to brachium. PTT was the pulse transit time between the brachial and tibial arterial waveforms. Mean right and left baPWV value was calculated during the analysis. All measurements were conducted by a single examiner who was blinded to the clinical data.
Statistical analysis
SPSS 17.0 software was used to perform the statistical analysis. The clinical and chemical parameters were compared according to bilirubin quartiles. Data were expressed as means ± SD or median (IQR) or percentage. The Chisquare statistical test or Fisher's exact test was used for all categorical variables, while one-way ANOVA was used for continuous all variables. Simple and multiple linear regression analyses were used to assess the correlation between baPWV and serum total bilirubin. Variables such as AST, ALT, GGT, ALP, Cho, SPB, DBP, BUN, Cr, TC, TG, HDL-C, and LDL-C were logarithmically transformed before statistical analysis to approximate normal distribution. p<0.05 was considered statistically significant.
Results
The clinical and laboratory characteristics of the patients according to serum TB tertiles are summarized in Table 1 . The age of the enrolled patients ranged from 25 to 86 years (women, 25-81 years; men, 34-86 years) with a mean age of 64.6±10.5 years (women, 67.3±8.3 years; men, 62.9±11.4 years). The mean age did not significantly differ among each serum total bilirubin quartile group in men and women. In men, BMI, SBP, DBP, ALP, Cho, UA and LDL-C decreased gradually as TB increased. However, only the statin intake and LDL-C decreased gradually as TB increased in women. The BMI, SBP, DBP, Cho and UA were not significantly different among the patients with all three TB tertiles in women.
The mean and standard error of baPWV according to TB tertiles are shown in Figure Univariate analysis showed that age, BMI, TB, ALT, GGT, Cho, SBP, DBP, UA, and TC were significantly associated with baPWV in men. In women, age, BMI, current smoker, Cho, SBP, DBP, UA, TC, TG, HDL-C, and LDL-C were significantly associated with baPWV (Table 2) .
Seventeen variables including age, current smoker, BMI, SBP, DBP, AST, ALT, GGT, ALP, Cho, UA, TC, TG, HDL-C, LDL-C and TB were entered into the model. The results showed that BMI, LnSBP, UA, TB, LnCho, and LnTC were correlated with baPWV in men in the multivariate model. However, only LnSBP, UA, and LnHDL-C were correlated with baPWV in women (Table 3) . TB was found to be a significant determinant for decreased baPWV only in men (β=-0.136; p<0.001).
Discussion
In this study, we found that serum bilirubin levels at the low end of the normal range are related with a significantly higher prevalence of cardiovascular disease (CVD) and baPWV decreased with increased TB in CAD. Moreover, our model suggests that bilirubin may have a potential role in protecting against atherosclerosis. Multiple regression analysis further identified TB as an independent and significant determinant for reduced baPWV.
Bilirubin, once considered a waste metabolite of heme catabolism, has recently been found to be an effective antioxidant and is positively correlated with the total antioxidant capacity in Gilbert's syndrome (25) . A lower prevalence of CVD was found in Gilbert's syndrome (26) . In previous studies, inverse associations have been shown not only between serum bilirubin concentrations and CVD, but also between bilirubin and peripheral vascular disease, carotidimtima-media thickness and stroke (27, 28) . Furthermore, a meta-analysis by Novotný et al. (29) of eleven studies has shown an inverse and dose-dependent relationship between serum bilirubin and different types and severities of CVD. The present results are consistent with previous findings and a further proof of our hypothesis that serum bilirubin is related to baPWV in CVD as well. Atherosclerosis appears to be a multifactorial disease and cannot be explained merely by subendothelial infiltration of certain lipid protein. Although a causal or resultant relationship between serum bilirubin and atherosclerosis is yet to be established, there is some indirect evidence which suggests that bilirubin may be anti-atherosclerotic. Previous studies have shown that bilirubin exerts an antioxidant effect (30, 31) . Antioxidative agents are known to act against the formation of atheromatous lesions in animal models and in humans (32, 33) . Higher serum bilirubin levels within a certain range indicate a good prognosis (34) , whereas much higher levels may imply bad outcomes (35) . The protective effect of bilirubin could be traced back to its catalytic enzyme, heme oxygenase. Heme oxygenase, comprising heme oxygenase-1 (HO-1), heme oxygenase-2 and heme oxygenase-3, functions as the rate-limiting enzyme in the degradation of heme, which leads to the formation of equimolar amounts of biliverdin, free ferrous iron and carbon monoxide. HO-1 and heme degradation products could attenuate complement-mediated acute inflammation and protect human vascular endothelial cells against complement-mediated injury. HO-1 and heme degradation products can preserve vascular NO and improve vascular function (36).
Non-invasive aortic stiffness measurement is postulated to be a surrogate marker of early atherosclerosis. An automated computer-assisted baPWV measurement facilitates a valid and reproducible assessment of arterial stiffness that is closely associated with invasive measurements of aortic stiffness (4). BaPWV reflects the stiffness of both the central and peripheral muscular arteries and serves as a simple index of the severity of arterial stiffness and atherosclerosis (37). Recent reports have shown an association between CVD and baPWV (38). Another study reported that an increased baPWV is associated with a poor prognosis in patients with CAD (39) and heart failure (40). The study that aerobic exercise resulted in reduced arterial stiffness confirmed the interaction between aging of muscle and atherosclerosis (41). However, the association was only shown in males (42). Consistent with the results, the present study also showed that bilirubin level is inversely associated with Table 1 . a, Log transformation was performed to normally distribute the data prior to analysis. baPWV only in men. Estrogen levels may be responsible for the sex disparity. Estrogen exerts beneficial effects on arterial stiffness (43). In addition, estrogen and androgen receptors expressed in vascular smooth muscle cell are also related to stiffness differences in different sexes (44, 45). Age was significantly associated with baPWV in men by Standardized regression coefficients. Abbreviations: see Table 1 . a Log transformation was performed to normally distribute the data prior to analysis.
the univariate analysis, but it was excluded from the significant determinants by the multivariate analysis in this study. This result might be due to the particularity of this population. All patients enrolled in this study were diagnosed with established CAD. Additionally, the number of patients was relatively small and the results of this study need to be assessed in a study with a larger sample size.
In conclusion, our findings show that the level of total serum bilirubin is negatively correlated with arterial stiffness in men with established CAD. Methods to increase serum bilirubin concentrations may be beneficial, especially with regard to atherosclerosis and CVD prevention. Further studies involving various bilirubin-enhancing drugs need to be investigated in order to provide evidence that slightly increased bilirubin concentrations are useful.
